Next 10 |
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX) , a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected t...
2024-04-07 11:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-03 17:24:42 ET Gainers: Signature Bank ( OTC:SBNY ) +10% . MacroGenics ( MGNX ) +9% . Simulations Plus ( SLP ) +7% . Annexon ( ANNX ) +6% . 2seventy ( TSVT ) +5% . Losers: Cadiz ( CDZIP ) -11% . ...
BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today...
2024-04-03 01:10:40 ET Summary Annexon, Inc. is a clinical stage biotech company that is close to releasing topline data on its lead therapy, ANX005. ANX005 has the potential to become the first FDA approved therapy for Guillain-Barré syndrome (GBS). GBS is a rare disease...
2024-04-01 08:53:49 ET More on the markets My Current View Of The Market: April 2024 Edition (Technical Analysis) SPY: Potential, Yes, But Risks Ahead Too Where This Market Is Going (Technical Analysis) Investors are sellers of fund assets for the second cons...
2024-04-01 07:30:05 ET Wells Fargo analyst issues OVERWEIGHT recommendation for ANNX on April 1, 2024 05:50AM ET. The previous analyst recommendation was Overweight. ANNX was trading at $7.17 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-01 07:00:05 ET Derek Archila from Wells Fargo issued a price target of $12.00 for ANNX on 2024-04-01 05:50:00. The adjusted price target was set to $12.00. At the time of the announcement, ANNX was trading at $7.17. ANNX currently trades -14.64% versus its 52 wee...
2024-03-28 12:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-26 17:28:35 ET More on Annexon Biosciences Seeking Alpha’s Quant Rating on Annexon Biosciences Historical earnings data for Annexon Biosciences Financial information for Annexon Biosciences Read the full article on Seeking Alpha For fur...
News, Short Squeeze, Breakout and More Instantly...
Annexon Inc. Company Name:
ANNX Stock Symbol:
NASDAQ Market:
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX) , a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected t...
2024-04-07 11:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical pl...